Corsair Pharma: Funding, Investors & Team (Sep 2026)
Corsair Pharma aims to revolutionize the therapeutic characteristics of medications, delivering enhanced treatment options for patients.
Corsair Pharma has raised $23.0M across 1 funding round on record, the most recent a Series B of $23.0M announced in Sep 2023.
That round is below the $38M median round size for Pharmaceutical Manufacturing companies tracked on FundedIQ over the last two years.
Corsair Pharma Company Profile and Key Stats
Latest funding round on record: Sep 2023.
Corsair Pharma Funding Rounds
Corsair Pharma Founders and Leadership Team
Contact details for the Corsair Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Corsair Pharma Funding Compared to Other Pharmaceutical Manufacturing Startups
Corsair Pharma's latest round of $23.0M is below the median round in Pharmaceutical Manufacturing. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Corsair Pharma in Pharmaceutical Manufacturing and Sunnyvale
Companies Similar to Corsair Pharma
India Globalization Capital, Inc. (IGC) operates as a materials and infrastructure company in India and…
Juniper Biosciences are at the forefront of transforming healthcare with revolutionary radiopharmaceuticals.
LENZ Therapeutics is a late-stage clinical startup creating novel, vision-improving ophthalmic prescription…
Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development.
ProFound Therapeutics is creating profound impacts on the understanding of biology and disease and the…
A multi-format private capital intelligence platform.
TRAXyL invented a new way to install broadband communications by essentially "painting" optical fiber…
Electric Pickle features pickleball courts, outdoor entertainment, and a restaurant with globally inspired…
Atorie is an online platform connecting luxury factories with customers that handles everything from…
Platform Therapeutics develops therapies for chemotherapy toxicities and dialysis-related muscle cramps.
NantOptiFab builds advanced photonic chips and wafers for telecom, AI, defense, and quantum applications.
Babynetic is a baby gear company creating stylish, safe, innovative products using patented magnetic designs…
Corsair Pharma Funding FAQs
What does Corsair Pharma do?
Corsair Pharma aims to revolutionize the therapeutic characteristics of medications, delivering enhanced treatment options for patients.
How much funding has Corsair Pharma raised?
Corsair Pharma has raised $23.0M across 1 round on record. The most recent is a Series B of $23.0M announced in Sep 2023.
When did Corsair Pharma last raise funding?
Corsair Pharma's most recent funding round on record is a Series B of $23.0M, announced in Sep 2023.
Who is the CEO of Corsair Pharma?
Bobby Singh is listed as CEO at Corsair Pharma.
Where is Corsair Pharma headquartered?
Corsair Pharma is based in Sunnyvale, California, United States.
How many employees does Corsair Pharma have?
Corsair Pharma is in the 1-10 employee band.
How does Corsair Pharma's funding compare to other Pharmaceutical Manufacturing startups?
Corsair Pharma's latest round of $23.0M is below the $38M median round size for Pharmaceutical Manufacturing companies on FundedIQ across 7 tracked companies over the last two years.
About FundedIQ's Corsair Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Corsair Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.